Infection Control And Biosafety Products Market

By Product Type;

Disinfectants & Antiseptics, Personal Protective Equipment (PPE), Surface Cleaners & Sanitizers, Infection Control Devices and Sterilization Equipment

By End User;

Hospitals & Healthcare Facilities, Long-Term Care Facilities, Laboratories, Pharmaceutical & Biotechnology Companies and Home Healthcare Providers

By Application Area;

Healthcare Settings, Laboratory Settings, Food Processing & Handling, Agriculture & Animal Husbandry and Public Spaces & Institutions

By Distribution Channel;

Online Retail, Direct Sales, Distributors & Wholesalers, Pharmacies & Drugstores and Specialized Stores

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn922690620 Published Date: September, 2025 Updated Date: November, 2025

Infection Control And Biosafety Products Market Overview

Infection Control And Biosafety Products Market (USD Million)

Infection Control And Biosafety Products Market was valued at USD 16,145.37 million in the year 2024. The size of this market is expected to increase to USD 28,132.73 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.3%.


Infection Control And Biosafety Products Market

*Market size in USD million

CAGR 8.3 %


Study Period2025 - 2031
Base Year2024
CAGR (%)8.3 %
Market Size (2024)USD 16,145.37 Million
Market Size (2031)USD 28,132.73 Million
Market ConcentrationMedium
Report Pages382
16,145.37
2024
28,132.73
2031

Major Players

  • 3M Company
  • STERIS plc
  • Ecolab Inc.
  • Johnson & Johnson Services Inc.
  • Halyard Health Inc. (now part of Owens & Minor)
  • Cardinal Health Inc.
  • Becton Dickinson and Company
  • Getinge AB
  • Thermo Fisher Scientific Inc.
  • Belimed AG
  • Mölnlycke Health Care AB
  • Advanced Sterilization Products
  • Danaher Corporation
  • Reckitt Benckiser Group plc
  • Sempermed USA Inc.
  • DuPont de Nemours Inc.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Infection Control And Biosafety Products Market

Fragmented - Highly competitive market without dominant players


The Infection Control and Biosafety Products Market is witnessing robust growth as healthcare facilities and laboratories intensify their focus on contamination prevention and safety standards. Rising concerns about infection transmission have fueled demand, with about 45% of medical institutions boosting investments in biosafety solutions to ensure reliable protection and efficiency.

Rising Demand for Safety Solutions
The demand for protective gear, sterilization devices, and disinfectants has increased substantially. More than 50% of laboratories and healthcare centers have integrated biosafety cabinets and advanced sterilization practices, reflecting a broader shift toward stringent safety compliance across various industries.

Technological Advancements Driving Adoption
Modern infection control products are evolving with innovations like antimicrobial coatings, automation, and smart monitoring systems. Nearly 40% of new biosafety installations now utilize advanced monitoring capabilities, enhancing precision and reliability in contamination control, while offering improved efficiency for end-users.

Focus on Healthcare Worker Protection
Healthcare workers remain a priority for safety initiatives, with over 55% of hospitals increasing the use of protective clothing, gloves, and respiratory masks. This growing focus on worker protection not only minimizes pathogen exposure but also boosts productivity by reducing illness-related disruptions in healthcare environments.

Future Growth Outlook
The Infection Control and Biosafety Products Market is set for steady expansion, supported by trends in workplace hygiene, innovation, and investment. Approximately 60% of organizations are planning higher allocations for biosafety technologies, highlighting the sector’s strong prospects. Continuous product enhancements and strategic collaborations will ensure sustained growth.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By End-User
    3. Market Snapshot, By Application Area
    4. Market Snapshot, By Distribution Channel
    5. Market Snapshot, By Region
  4. Infection Control And Biosafety Products Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of infectious diseases
        2. Growing healthcare infrastructure and awareness
        3. Government initiatives and regulations for infection control
      2. Restraints
        1. Limited access to infection control products in developing regions
        2. Stringent regulatory requirements for product approval
        3. Lack of skilled professionals for proper implementation
      3. Opportunities
        1. Expansion of infection control in emerging markets
        2. Technological advancements in infection control products
        3. Increasing focus on preventive healthcare
        4. Rising adoption of automated and smart biosafety systems
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Infection Control And Biosafety Products Market, By Product Type, 2021 - 2031 (USD Million)
      1. Disinfectants and Antiseptics
      2. Personal Protective Equipment (PPE)
      3. Surface Cleaners and Sanitizers
      4. Infection Control Devices
      5. Sterilization Equipment
    2. Infection Control And Biosafety Products Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals and Healthcare Facilities
      2. Long-Term Care Facilities
      3. Laboratories
      4. Pharmaceutical and Biotechnology Companies
      5. Home Healthcare Providers
    3. Infection Control And Biosafety Products Market, By Application Area, 2021 - 2031 (USD Million)
      1. Healthcare Settings
      2. Laboratory Settings
      3. Food Processing and Handling
      4. Agriculture and Animal Husbandry
      5. Public Spaces and Institutions
    4. Infection Control And Biosafety Products Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Online Retail
      2. Direct Sales
      3. Distributors and Wholesalers
      4. Pharmacies and Drugstores
      5. Specialized Stores
    5. Infection Control And Biosafety Products Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. 3M Company
      2. STERIS plc
      3. Ecolab Inc.
      4. Johnson & Johnson Services Inc.
      5. Halyard Health Inc. (now part of Owens & Minor)
      6. Cardinal Health Inc.
      7. Becton Dickinson and Company
      8. Getinge AB
      9. Thermo Fisher Scientific Inc.
      10. Belimed AG
      11. Mölnlycke Health Care AB
      12. Advanced Sterilization Products
      13. Danaher Corporation
      14. Reckitt Benckiser Group plc
      15. Sempermed USA Inc.
      16. DuPont de Nemours Inc.
  7. Analyst Views
  8. Future Outlook of the Market